PURPOSE: To describe the clinical manifestation and course of chorioretinitis presumed to be secondary to coxsackievirus infection in an adult. METHOD: Case report documented by fundus photography and fluorescein angiography. RESULTS: Ophthalmoscopic examination of a symptomatic 34-year-old woman showed several cream-colored parafoveal spots at the level of the retinal pigment epithelium and similar, multiple confluent spots in the midperiphery of both eyes. Titers for coxsackievirus B4 demonstrated a fourfold rise between acute and convalescent sera. CONCLUSION: Coxsackievirus B4 is apparently a rare cause of chorioretinitis but nevertheless should be considered in the appropriate clinical setting.
PURPOSE: To describe the clinical manifestation and course of chorioretinitis presumed to be secondary to coxsackievirus infection in an adult. METHOD: Case report documented by fundus photography and fluorescein angiography. RESULTS: Ophthalmoscopic examination of a symptomatic 34-year-old woman showed several cream-colored parafoveal spots at the level of the retinal pigment epithelium and similar, multiple confluent spots in the midperiphery of both eyes. Titers for coxsackievirus B4 demonstrated a fourfold rise between acute and convalescent sera. CONCLUSION:Coxsackievirus B4 is apparently a rare cause of chorioretinitis but nevertheless should be considered in the appropriate clinical setting.
Authors: Cecilia S Jung; John F Payne; Chris S Bergstrom; Blaine E Cribbs; Jiong Yan; G Baker Hubbard; Timothy W Olsen; Steven Yeh Journal: Arch Ophthalmol Date: 2012-01
Authors: Rupesh Agrawal; Kanchan Bhan; Kam Balaggan; Richard Wj Lee; Carlos E Pavesio; Peter Kf Addison Journal: J Ophthalmic Inflamm Infect Date: 2015-02-01
Authors: Alexa L Li; Neal V Palejwala; Jessica G Shantha; Ghazala O'Keefe; Cecilia S Lee; Thomas Albini; Steven Yeh Journal: PLoS One Date: 2020-08-24 Impact factor: 3.752
Authors: Michael Reich; Bertan Cakir; Stevan Cvetkoski; Stefan J Lang; Andreas Stahl; Thomas Ness; Hansjürgen Agostini; Clemens Lange Journal: BMC Ophthalmol Date: 2019-05-07 Impact factor: 2.209